| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 05/13/2004 | US20040092592 Mixture of arginine, magnesium salt of 2-amino-5-guanidinovaleric acid and anticoagulant; antideposit agent for arteries plaque; cardiovascular disorders |
| 05/13/2004 | US20040092583 Treatment for inhibiting neoplastic lesions |
| 05/13/2004 | US20040092571 Antilipemic agents; anticholesterol agents; synergistic mixtures of n-(1-octyl-5-carboxy-4,6-dimethylinsol-7-yl)-2,2-dimethylpropanamide compound and enzyme inhibitor |
| 05/13/2004 | US20040092568 Administering kinase inhibitor |
| 05/13/2004 | US20040092565 Synergistic mixture; anticancer agents; enhance penetration of cancer cells |
| 05/13/2004 | US20040092551 Piperidine derivatives useful as CCR5 antagonists |
| 05/13/2004 | US20040092550 Anticholesterol agents; cardiovascular disorders |
| 05/13/2004 | US20040092544 Synergistic mixture containing dopamine agent; muscular disorders; analgesics |
| 05/13/2004 | US20040092542 Tamper-resistant oral opioid agonist formulations |
| 05/13/2004 | US20040092541 Analgesic mixture; side effect reduction |
| 05/13/2004 | US20040092540 Compositions useful for the treatment of pathologies responding to the activation of ppar-gamma receptor |
| 05/13/2004 | US20040092536 Side effect reduction; muscular disorders; trauma |
| 05/13/2004 | US20040092532 Use of p38 inhibitors for the treatment of smoke inhalation |
| 05/13/2004 | US20040092531 Active substance combination containing an opioid having a fentanyl-type structure and ketamine |
| 05/13/2004 | US20040092530 Administering mixture of alanine and serine |
| 05/13/2004 | US20040092528 Brain disorders; psychological disorders; Alzheimer's disease; Parkinson's disease; schizophrenia |
| 05/13/2004 | US20040092523 Method for the treatment of heart failure |
| 05/13/2004 | US20040092519 New treatment for hot flashes |
| 05/13/2004 | US20040092511 Mixture containing antiserotonine agents |
| 05/13/2004 | US20040092508 Treatment of affective disorders by the combined action of a nicotinic receptor agonist and a monoaminergic substance |
| 05/13/2004 | US20040092507 Melanocortin receptor agonists |
| 05/13/2004 | US20040092506 Administering estrogen antagonist; skin disorders; wrinkle resistance; antiarthritic agents; anticancer agents; wound healing agents |
| 05/13/2004 | US20040092501 Acylated piperidine derivatives as melanocortin-4 receptor agonists |
| 05/13/2004 | US20040092500 Methods and therapeutic combinations for the treatment of demyelination |
| 05/13/2004 | US20040092499 Methods and therapeutic combinations for the treatment of autoimmune disorders |
| 05/13/2004 | US20040092496 Anticancer agents; destroying cancer, warts |
| 05/13/2004 | US20040092493 Method for ameliorating male erectile dysfunction |
| 05/13/2004 | US20040092486 Modulation of smr1-nep interactions in cns disorders giving rise to mental disorders |
| 05/13/2004 | US20040092481 Eating disorders; irritable bowel disorders; headaches; obsessive compulsive disorders |
| 05/13/2004 | US20040092478 Combinations comprising an antidiarrheal agent and an epothilone or an epothilone derivative |
| 05/13/2004 | US20040092477 Compositions for the treatment and prevention of arterial thrombosis and use of an inhibitor of factor Xa alone and/or in combination with an anti-platelet aggregation agent |
| 05/13/2004 | US20040092472 Nucleic acid compositions for stimulating immune responses |
| 05/13/2004 | US20040092470 Dry powder oligonucleotide formualtion, preparation and its uses |
| 05/13/2004 | US20040092453 Synergistic antineoplastic effect; side effect reduction |
| 05/13/2004 | US20040092445 Increasing hematopoietic progenitor cells in a mammal by adminstering an interleukin-like polypeptide |
| 05/13/2004 | US20040092436 Immunosuppressive imidazole derivatives and their combination preparations with tacrolimus of cyclosporins |
| 05/13/2004 | US20040092434 Oligopeptides; antitumor agents, antiinflammatory agents, antiischemic agents, vision defects |
| 05/13/2004 | US20040092433 Use of zwitterionic polysaccharides for the specific modulation of immune processes |
| 05/13/2004 | US20040092427 Method and composition for treating alzheimer's disease and dementias of vascular origin |
| 05/13/2004 | US20040091996 Genetically engineered virus which propagates specifically in tumor cells and codes angiogensis inhibitors; antitumor/antiproliferative agents |
| 05/13/2004 | US20040091955 Process and compositions for peptide, protein and peptidomimetic synthesis |
| 05/13/2004 | US20040091951 Assay for measuring acetylation or deacetylation activity of an enzyme |
| 05/13/2004 | US20040091947 Screening strategy for anticancer drugs |
| 05/13/2004 | US20040091942 Measuring concentration of phospho-tau protein in body/brain fluids for detecting alzheimer's, nervous system and brain disorders |
| 05/13/2004 | US20040091912 Diagnostic method |
| 05/13/2004 | US20040091907 GEF-H1b: biomarkers, complexes assays and therapeutic uses thereof |
| 05/13/2004 | US20040091895 Human sprouty-4 polypeptide |
| 05/13/2004 | US20040091559 Compositions for diabetes treatment and prophylaxis |
| 05/13/2004 | US20040091556 For topical application and saturation of portions of sinus physiology, for therapy of cold or flu |
| 05/13/2004 | US20040091554 Nutritional supplement containing alpha-glucosidase and alpha-amylase inhibitors |
| 05/13/2004 | US20040091551 Topical composition and application system |
| 05/13/2004 | US20040091548 A topical antiinflammatory composition of hydrogen peroxide to cleanse the skin, a moisturizer to facilitate hydration and an antiinflammatory agent; skin disorders, e.g., dermatitis, psoriasis, folliculitis, rosacea, acne, impetigo |
| 05/13/2004 | US20040091540 Method for restoring a damaged or degenerated intervertebral disc |
| 05/13/2004 | US20040091533 A safe and effective twelve to twenty-four hour formulation comprising a decongestant core which has a delay release coating and an immediate release coating of both drugs, a water soluble binder and surfactant; one-a-day orally |
| 05/13/2004 | US20040091527 Method of increasing the bioavailability and tissue penetration of azithromycin |
| 05/13/2004 | US20040091526 A graphic art marking of a pregnant women, is used to prevent erroneous dispensing of or erroneous ingestion of drugs not intended for pregnant women, improve patient compliance, product effectiveness |
| 05/13/2004 | US20040091525 Pharmaceutical composition formulated for pre-gastric absorption of monoamine oxidase B inhibitor component |
| 05/13/2004 | US20040091509 Skin care composition that mediates cell to cell communication |
| 05/13/2004 | US20040091508 Rapidly absorbed liquid compositions |
| 05/13/2004 | US20040091507 Rapidly absorbed liquid compositions |
| 05/13/2004 | US20040091506 Topical antifungal treatment |
| 05/13/2004 | US20040091498 Defensins: use as antiviral agents |
| 05/13/2004 | US20040091497 Use as a biological target for the treatment and diagnosis of schizophrenia and bipolar disorder for example; drug screening; transgenic non-human animals for use as animal models |
| 05/13/2004 | US20040091493 Active ingredient such as specified plant extract(s) or calcium compound that does not cause any inflammatory, irritation or intolerance reactions; tissue models for drug screening for drugs against skin disorders; dandruff, acne |
| 05/13/2004 | US20040091491 An immune response modifier portion such as a Toll-like receptor or an imidazoquinoline compound paired with an antigenic portion; use of toll-like receptor improves immune response over conventional immune response modifiers |
| 05/13/2004 | US20040091484 Antigen binding fragments that specifically detect cancer cells, nucleotides encoding the fragments, and use thereof for the prophylaxis and detection of cancers |
| 05/13/2004 | US20040091481 Method for modulating the binding activity of a novel icam-3 binding receptor on sinusoidal endothelial cells in liver and lymph nodes |
| 05/13/2004 | US20040091477 Immunophilin-binding compound and ginkgolide compound |
| 05/13/2004 | US20040091476 Enhance or suppress T-cell activation and proliferation |
| 05/13/2004 | US20040091468 Novel transcriptional mediators of blood vessel development and endothelial differentiation |
| 05/13/2004 | US20040091462 Composition for the carrying and delivery of bone growth inducing material and methods for producing and applying the composition |
| 05/13/2004 | US20040091448 Disinfecting dip compositions and related methods |
| 05/13/2004 | US20040091423 Methods for identifying asymptomatic patients who have a likelihood of benefiting from administration of an estrogen activity modulator for risk reduction or therapeutic treatment of breast cancer, methods for reducing risk or |
| 05/13/2004 | US20040091421 The invention relates to an internal therapeutic product comprising: (i) an anti-cancer component selected from one or both of: a radionucleotide, a cytotoxic drug; and (ii) a silicon component selected from one or more of: resorbable |
| 05/13/2004 | DE10250870A1 Zusammensetzung enthaltend Aktivatoren von IK-Kaliumkanälen und Calcineurin-Antagonisten und deren Verwendung Composition containing activators of IK potassium channels and calcineurin antagonists and their use |
| 05/13/2004 | DE10249552A1 Wasserlösliche Eisen-Kohlenhydrat-Komplexe, deren Herstellung und diese enthaltende Arzneimittel Water-soluble iron-carbohydrate complexes, their preparation and pharmaceutical compositions containing them |
| 05/13/2004 | CA2503841A1 Therapeutic compositions |
| 05/13/2004 | CA2503624A1 Use of a nitric oxide donor to prevent desensitization of g-protein coupled receptors |
| 05/13/2004 | CA2503616A1 Treatment of pain with jnk inhibitors |
| 05/13/2004 | CA2503422A1 Compositions for cancer treatment |
| 05/12/2004 | EP1417975A1 REMEDIES FOR DISEASES WITH BONE MASS LOSS HAVING EP sb 4 /sb AGONIST AS THE ACTIVE INGREDIENT |
| 05/12/2004 | EP1417967A1 Novel virus proliferation inhibition/virucidal method and novel pyradine nucleotide/pyradine nucleoside analogue |
| 05/12/2004 | EP1417959A1 Tablet for buccal, sublingual or gingival administration, comprising an effervescent couple |
| 05/12/2004 | EP1417349A2 Novel molecular target for neurotoxicity |
| 05/12/2004 | EP1417342A2 Methods for diagnosing and treating diseases and conditions of the digestive system and cancer |
| 05/12/2004 | EP1417340A2 Method for the detection of a polymorphism in cpb2 |
| 05/12/2004 | EP1417232A2 Human monoclonal antibodies to epidermal growth factor receptor (egfr) |
| 05/12/2004 | EP1417224A2 Secreted proteins |
| 05/12/2004 | EP1417217A2 Inhibition of behab cleavage and primary central nervous system (cns) tumors |
| 05/12/2004 | EP1417182A1 Compounds useful for treatment or prevention of disease mediated by alpha-2b-adrenoceptor |
| 05/12/2004 | EP1417055A2 Use of copper chelators to inhibit the inactivation of protein c |
| 05/12/2004 | EP1416962A2 Method of improving cognitive function |
| 05/12/2004 | EP1416961A1 Composition and method for the treatment of disease |
| 05/12/2004 | EP1416960A1 Vegfr-1 antibodies to treat breast cancer |
| 05/12/2004 | EP1416952A1 Regulation of the apj receptor for use in the treatment or prophylaxis of cardiac diseases |
| 05/12/2004 | EP1416942A1 Method for treating gout and binding uric acid |
| 05/12/2004 | EP1416941A1 Compositions for the treatment and prevention of pain and inflammation with a cyclooxygenase-2 selective inhibitor and chondroitin sulfate |
| 05/12/2004 | EP1416940A1 Compositions for the treatment and prevention of pain and inflammation with a cyclooxygenase-2 selective inhibitor and glucosamine |
| 05/12/2004 | EP1416939A2 Method of treating malignancy associated hypercalcemia using active vitamin d analogues |
| 05/12/2004 | EP1416932A1 New dipeptidyl peptidase iv inhibitors and their uses for lowering blood pressure levels |